RxDoctor Payments Data

Jenna Weyler, PA

Physician Assistant · Centerville, OHNPI 1336854439

Payments from drug & device makers

$10,060in general payments, 2019–2025

Across 454 payments — averaging $22.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • EMD Serono, Inc.$1K
  • MDD US Operations, LLC$840
  • Lilly USA, LLC$805
  • UCB, Inc.$583
  • Pfizer$550
  • plus $5K from 34 others

What the payments were for

  • Speaking & faculty fees$130%
  • Food & beverage$10,047100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,060 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$56,849
Medicare patients
312
Services billed
592

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AubagioTeriflunomide27$259,702
UbrelvyUbrogepant70$82,657
Nurtec OdtRimegepant Sulfate38$46,001
QuliptaAtogepant42$44,720
BriviactBrivaracetam18$40,475
FycompaPerampanel13$17,747
Emgality PenGalcanezumab-Gnlm20$15,863
Ajovy AutoinjectorFremanezumab-Vfrm13$10,451
Rivastigmine25$7,210
Memantine Hcl281$6,646
Topiramate ErTopiramate11$3,874
Pregabalin120$3,720
Gabapentin265$2,984
Duloxetine Hcl163$2,249
Lacosamide19$2,079

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
SanofiAubagio$53$259,70227 claims
AbbVieUbrelvy, Qulipta$1,608$127,376112 claims
PfizerNurtec Odt$550$46,00138 claims
UCB, Inc.Briviact$583$40,47518 claims
Eisai Inc.Fycompa$366$17,74713 claims
Amneal Pharmaceuticals LLCPyridostigmine Bromide$290$78520 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Centerville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →